0.8798
price up icon2.85%   0.0244
after-market アフターアワーズ: .87 -0.0098 -1.11%
loading
前日終値:
$0.8554
開ける:
$0.87
24時間の取引高:
405.51K
Relative Volume:
0.65
時価総額:
$95.95M
収益:
-
当期純損益:
$-26.91M
株価収益率:
-3.9991
EPS:
-0.22
ネットキャッシュフロー:
$-19.57M
1週間 パフォーマンス:
+18.44%
1か月 パフォーマンス:
+46.36%
6か月 パフォーマンス:
-37.16%
1年 パフォーマンス:
-47.00%
1日の値動き範囲:
Value
$0.847
$0.8998
1週間の範囲:
Value
$0.72
$0.9265
52週間の値動き範囲:
Value
$0.5526
$1.81

Atossa Therapeutics Inc Stock (ATOS) Company Profile

Name
名前
Atossa Therapeutics Inc
Name
セクター
Healthcare (1150)
Name
電話
206.588.0256
Name
住所
10202 5TH AVENUE NE, SEATTLE, WA
Name
職員
13
Name
Twitter
@atossainc
Name
次回の収益日
2025-03-25
Name
最新のSEC提出書
Name
ATOS's Discussions on Twitter

ATOS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ATOS
Atossa Therapeutics Inc
0.8798 95.95M 0 -26.91M -19.57M -0.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.19 127.64B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
603.58 65.95B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
656.65 37.92B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
273.55 32.98B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
254.16 26.92B 3.81B -644.79M -669.77M -6.24

Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2018-01-26 開始されました Maxim Group Buy

Atossa Therapeutics Inc (ATOS) 最新ニュース

pulisher
09:06 AM

Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Mid Florida Newspapers

09:06 AM
pulisher
May 03, 2025

JPMorgan Chase & Co. Buys 211,654 Shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

May 03, 2025
pulisher
May 02, 2025

ATOS: Atossa Therapeutics Secures New Patent for (Z)-endoxifen Formulations | ATOS Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

A look into Atossa Therapeutics Inc (ATOS)’s deeper side - Sete News

May 02, 2025
pulisher
May 02, 2025

LPL Financial LLC Cuts Stock Position in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

May 02, 2025
pulisher
May 01, 2025

Atossa Therapeutics reports progress in breast cancer treatments - MSN

May 01, 2025
pulisher
May 01, 2025

Atossa Therapeutics Inc (ATOS)’s results reveal risk - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics Inc (ATOS) rating initates by Maxim Group - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Sector Update: Health Care - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics (ATOS) Secures Patent for Key Breast Cancer Drug Formulations - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa stock gains on U.S. patent win (ATOS:NASDAQ) - Seeking Alpha

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics Inc (ATOS) Stock: Navigating a Year of Volatility - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics Gets US Patent Covering (Z)-endoxifen Breast Cancer Treatment - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281 - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics (ATOS) Secures Patent for Innovative Drug Fo - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics secures new patent for breast cancer drug By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio - The Manila Times

Apr 30, 2025
pulisher
Apr 30, 2025

Atossa Therapeutics secures new patent for breast cancer drug - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Major Patent Breakthrough: Atossa's Cancer Drug Portfolio Expands with 58 New Protected Formulations - Stock Titan

Apr 30, 2025
pulisher
Apr 29, 2025

Atossa Therapeutics Proposes Potentially Groundbreaking Study Ai - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Atossa Therapeutics (ATOS) Launches SMART 2.0 Phase 3 Clinical S - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025 - The Manila Times

Apr 29, 2025
pulisher
Apr 29, 2025

Revolutionary Breast Cancer Prevention Trial Could Reduce Risk by 20% in High-Risk Women - Stock Titan

Apr 29, 2025
pulisher
Apr 29, 2025

Hilton (NYSE:HLT) Reports Sales Below Analyst Estimates In Q1 Earnings - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

Renaissance Technologies LLC Boosts Position in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Apr 29, 2025
pulisher
Apr 25, 2025

Stock Performance Spotlight: Atossa Therapeutics Inc (ATOS) Ends the Day at 0.73, Down by -0.73 - DWinneX

Apr 25, 2025
pulisher
Apr 24, 2025

ATOS’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Atossa Therapeutics announces issuance of U.S. patent - MSN

Apr 24, 2025
pulisher
Apr 24, 2025

Ascendiant Capital Markets Comments on ATOS Q1 Earnings - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Atossa Therapeutics (NASDAQ:ATOS) Price Target Raised to $7.25 at Ascendiant Capital Markets - American Banking and Market News

Apr 23, 2025
pulisher
Apr 23, 2025

What was Atossa Therapeutics Inc (ATOS)’s performance in the last session? - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Plus Therapeutics Strengthens Board: Former Atossa CFO Brings 30 Years of NYSE and NASDAQ Leadership - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Atossa Therapeutics secures new patent for breast cancer treatment By Investing.com - Investing.com South Africa

Apr 22, 2025
pulisher
Apr 22, 2025

Atossa Therapeutics (ATOS) Secures New U.S. Patent for (Z)-endoxifen Formulations - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Atossa Therapeutics secures new patent for breast cancer treatment - Investing.com

Apr 22, 2025
pulisher
Apr 22, 2025

Atossa Therapeutics (ATOS) Secures Patent for New (Z)-endoxifen Formulation | ATOS Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio | ATOS Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

New Patent Strengthens Atossa's Breast Cancer Drug Portfolio: What This Means for Treatment Innovation - Stock Titan

Apr 22, 2025
pulisher
Apr 22, 2025

Ascendiant Capital Markets Issues Positive Forecast for Atossa Therapeutics (NASDAQ:ATOS) Stock Price - Defense World

Apr 22, 2025
pulisher
Apr 18, 2025

Atossa Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com

Apr 18, 2025
pulisher
Apr 11, 2025

Atossa Therapeutics (ATOS) Partners with Nona Biosciences to Adv - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Nona Biosciences and Atossa Therapeutics Partner to Discover Nex - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer - The Manila Times

Apr 10, 2025
pulisher
Apr 10, 2025

Atossa and Nona partner on antibody research for breast cancer - The Pharma Letter

Apr 10, 2025
pulisher
Apr 08, 2025

Atossa Therapeutics (NASDAQ:ATOS) & Pharming Group (OTCMKTS:PHGUF) Critical Comparison - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Atossa Therapeutics says Intas Pharmaceuticals Filed Petition For Post Grant Review Against Co- SEC Filing - marketscreener.com

Apr 07, 2025
pulisher
Apr 03, 2025

Atossa Therapeutics’ Earnings Call Highlights Cost Reductions and Clinical Progress - MSN

Apr 03, 2025
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Lowers Stake in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

A closer look at Atossa Therapeutics Inc (ATOS)’s stock price trends - uspostnews.com

Apr 02, 2025
pulisher
Mar 31, 2025

Atossa Therapeutics (ATOS) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 31, 2025

Atossa Therapeutics Inc (ATOS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
大文字化:     |  ボリューム (24 時間):